Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Biotage
Biotage
Activities:
Research & Development
Analysis
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
N4 Pharma and SRI to target and treat previously unreachable human cells
The companies will collaborate to perform research to conjugate SRI’s MGS system to Nuvec to increase intracellular delivery to specific target cells.
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency
Partnership complements Gyros’ PurePep EasyClean technology offering with an automated solution for advanced discovery process
Regulatory
Biotage achieves Gold sustainability rating
EcoVadis,audited the company’s performance in several key areas, including environment, labour & human rights, ethics and sustainable procuremen
Finance
Biotage triples production capacity for vaccine-critical equipment
The availability of raw materials for vaccine production has been a major bottleneck
Analysis
Swedish Biotage taps into US market with PhyNexus acquisition
The California-based company specialises in lab-scale purification of biomolecules
Analysis
Biotage launches ACI (Accelerated Chromatographic Isolation)
Faster and more economical way to isolate pure compounds
Research & Development
Biotage launches integrated mass directed flash system
Reduces the number of steps required to purify and confirm a target compound
Manufacturing
Biotage unveils fully automated microwave peptide synthesiser
Robotic liquid handler and precise digital syringe pumps reduce reagent and solvent consumption
Subscribe now